Literature DB >> 11298649

P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract.

B Wullt1, G Bergsten, H Connell, P Röllano, N Gebratsedik, L Hang, C Svanborg.   

Abstract

Uropathogenic Escherichia coli elicit a host response that determines the severity of urinary tract infection (UTI). Specific adherence mechanisms allow the bacteria to initiate this process by targeting epithelial cells in the urinary tract mucosa. Epidemiological studies show a strong association of P-fimbriae with disease severity, suggesting that adherence mediated by these organelles has a direct effect on mucosal inflammation in vivo. The present study examined the ability of P-fimbriae to induce inflammation in the human urinary tract. Patients were subjected to intravesical inoculation with a non-fimbriated E. coli strain or transformants of this strain expressing P-fimbriae. The inflammatory response was analysed as a function of P-fimbrial expression. The P-fimbriated transformants invariably caused higher interleukin (IL)-8, IL-6 and neutrophil responses in the urinary tract than the ABU strain. Furthermore, loss of P-fimbrial expression in vivo was accompanied by a return to background levels of neutrophils, IL-6 and IL-8 in individual patients. The results demonstrate that the pap sequences confer on a non-fimbriated, avirulent strain the ability to induce a host response in the human urinary tract. P-fimbriae thus fulfil the 'molecular Koch-Henle postulates' linking a single virulence factor to host response induction.

Entities:  

Mesh:

Year:  2001        PMID: 11298649     DOI: 10.1046/j.1462-5822.2001.00111.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  24 in total

1.  Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli.

Authors:  Rebecca E Watts; Makrina Totsika; Victoria L Challinor; Amanda N Mabbett; Glen C Ulett; James J De Voss; Mark A Schembri
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 3.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

4.  Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen.

Authors:  Per Klemm; Viktoria Roos; Glen C Ulett; Catharina Svanborg; Mark A Schembri
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

5.  Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition.

Authors:  Scott A Beatson; Nouri L Ben Zakour; Makrina Totsika; Brian M Forde; Rebecca E Watts; Amanda N Mabbett; Jan M Szubert; Sohinee Sarkar; Minh-Duy Phan; Kate M Peters; Nicola K Petty; Nabil-Fareed Alikhan; Mitchell J Sullivan; Jayde A Gawthorne; Mitchell Stanton-Cook; Nguyen Thi Khanh Nhu; Teik Min Chong; Wai-Fong Yin; Kok-Gan Chan; Viktoria Hancock; David W Ussery; Glen C Ulett; Mark A Schembri
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

6.  Monitoring F1651 P-like fimbria expression at the single-cell level reveals a highly heterogeneous phenotype.

Authors:  Richard Graveline; Rémi Lavoie; Philippe Garneau; France Daigle; Serge Sénéchal; Christine Martin; Josée Harel
Journal:  Infect Immun       Date:  2015-02-23       Impact factor: 3.441

7.  Escherichia coli isolates causing asymptomatic bacteriuria in catheterized and noncatheterized individuals possess similar virulence properties.

Authors:  Rebecca E Watts; Viktoria Hancock; Cheryl-Lynn Y Ong; Rebecca Munk Vejborg; Amanda N Mabbett; Makrina Totsika; David F Looke; Graeme R Nimmo; Per Klemm; Mark A Schembri
Journal:  J Clin Microbiol       Date:  2010-05-05       Impact factor: 5.948

8.  Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates.

Authors:  S J Drews; S M Poutanen; T Mazzulli; A J McGeer; A Sarabia; S Pong-Porter; Y Rzayev; B Willey; K Green; D E Low
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

9.  Induction of interleukin-8 production via nuclear factor-kappaB activation in human intestinal epithelial cells infected with Vibrio vulnificus.

Authors:  B C Lee; S H Kim; S H Choi; T S Kim
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

10.  Regulation of P-fimbrial phase variation frequencies in Escherichia coli CFT073.

Authors:  Nicola Holden; Makrina Totsika; Lynn Dixon; Kirsteen Catherwood; David L Gally
Journal:  Infect Immun       Date:  2007-04-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.